Interact to see
Advertisement
Advertisement
TACAX vs VCLAX
TACAX vs VCLAX Comparison
Open Charts TACAX vs VCLAX
JHancock CA Municipal Bond A
Price$9.91
Change+$0.01 (+0.10%)
VolumeN/A
Net Assets540.26M
Vanguard CA Long-Term Tax-Exempt Adm
Price$11.51
Change+$0.01 (+0.09%)
VolumeN/A
Net Assets5.81B
TACAX vs VCLAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
TACAX vs. VCLAX commentary
Nov 27, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TACAX is a Hold and VCLAX is a Hold.
FUNDAMENTALS
Fundamentals
VCLAX has more cash in the bank: 5.81B vs. TACAX (540M). TACAX (3.66) and VCLAX (3.49) have matching dividends . TACAX was incepted earlier than VCLAX: TACAX (36 years) vs VCLAX (24 years). TACAX (0.87) is less costly to investors than VCLAX (0.09). VCLAX is a more actively managed with annual turnover of: 81.00 vs. TACAX (42.00). TACAX has a lower initial minimum investment than VCLAX: TACAX (1000) vs VCLAX (50000). TACAX annual gain was more profitable for investors over the last year : 1.03 vs. VCLAX (-0.61). TACAX return over 5 years is better than : 6.05 vs. VCLAX (-10.29).
| TACAX | VCLAX | TACAX / VCLAX | |
| Total Expense Ratio | 0.72 | 0.09 | 800% |
| Annual Report Gross Expense Ratio | 0.87 | 0.09 | 967% |
| Fund Existence | 36 years | 24 years | - |
| Gain YTD | 1.869 | 0.524 | 356% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 1000 | 50000 | 2% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 540M | 5.81B | 9% |
| Annual Yield % from dividends | 3.66 | 3.49 | 105% |
| Returns for 1 year | 1.03 | -0.61 | -171% |
| Returns for 3 years | 13.66 | 4.32 | 316% |
| Returns for 5 years | 6.05 | -10.29 | -59% |
| Returns for 10 years | 25.10 | -4.58 | -547% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BIB | 83.58 | 1.47 | +1.79% |
| ProShares Ultra Nasdaq Biotechnology | |||
| SPXX | 17.77 | 0.24 | +1.37% |
| Nuveen S&P 500 Dynamic Overwrite Fund | |||
| MLPD | 25.22 | 0.13 | +0.52% |
| Global X MLP & Engy Infras Cov Cll ETF | |||
| CLM | 8.27 | 0.04 | +0.49% |
| Cornerstone Strategic Value Fund | |||
| BMED | 30.93 | 0.10 | +0.34% |
| iShares Health Innovation Active ETF | |||